AlternativeMed
Ancient Wisdom Natural Remedies Modern Wellness
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

🌿
Herb
6,826
→
⚗️
Ingredient
44,595
→
🧬
Gene Target
15,505
→
🏥
Disease
30,170
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
Subject Type: 🌿 Herbs ⚗️ Ingredients 📜 Formulas 🧬 Targets 🏥 Diseases
Quick picks: Abetalipoproteinemia Abortion, Habitual Agenesis Acanthamoeba Keratitis Acanthosis Nigricans Achondrogenesis Achondroplasia Acne Vulgaris Acne Keloid Apert Syndrome
🏥 Disease / Health Topic

Her2-Negative Breast Cancer

Open on HERB 2.0 ↗
9
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT04150042
SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells
Recruiting · Phase 1
NCT00003440
Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic
Completed · Phase 3
NCT01705691
Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer
Completed · Phase 2
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Her2-Negative Breast Cancer
🏥 Names
Disease Name
Her2-Negative Breast Cancer
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
🔗 External References
HERB DB
HBDIS027949 ↗
DisGeNET
C4733095
🔍 Raw view — every non-empty column on this row (19 fields)
name
Her2-Negative Breast Cancer
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
umls disease type id
T191
herb disease id
HBDIS027949
disgenet id
C4733095

⚗️ Related Ingredients

2 · shared evidence
L-ascorbic acid
Taxol

📋 Clinical Trials

9 · subject of clinical study
NCT04150042 SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Usi
→ Pancreatic Adenocarcinoma Metastatic|BRCA1 Mutatio
NCT00003440 Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-
→ HER2-negative Breast Cancer|HER2-positive Breast C
NCT01705691 Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Follow
→ Breast Cancer|HER2-negative Breast Cancer
NCT00618657 Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in t
→ Breast Cancer|HER2-negative Breast Cancer|HER2-pos
NCT00733408 Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastat
→ Estrogen Receptor-negative Breast Cancer|HER2-nega
NCT03412643 Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negati
→ HER2-negative Breast Cancer
NCT04576143 Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemot
→ HER2-negative Breast Cancer|Neoadjuvant Chemothera
NCT05383196 Onvansertib + Paclitaxel in TNBC
→ Breast Cancer|Invasive Breast Cancer|Unresectable
NCT05275777 A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination W
→ HER2-negative Breast Cancer|Advanced Solid Tumor
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: empty — needs HERB_herb_ingredient import
  • Ingredient ↔ Target: empty — needs HERB_ingredient_target import
  • Target ↔ Disease: empty — needs HERB_target_disease import
  • Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables